[go: up one dir, main page]

HRP20151328T1 - POSTUPAK ZA PRIPRAVU BENZIL[(3aS,4R,6S,6aR)-6-HIDROKSI-2,2- DIMETILTETRAHIDRO-3aH-CIKLOPENTA[d][1,3]DIOKSOL]-4-IL]KARBAMATA I INTERMEDIJERI U POSTUPKU - Google Patents

POSTUPAK ZA PRIPRAVU BENZIL[(3aS,4R,6S,6aR)-6-HIDROKSI-2,2- DIMETILTETRAHIDRO-3aH-CIKLOPENTA[d][1,3]DIOKSOL]-4-IL]KARBAMATA I INTERMEDIJERI U POSTUPKU Download PDF

Info

Publication number
HRP20151328T1
HRP20151328T1 HRP20151328TT HRP20151328T HRP20151328T1 HR P20151328 T1 HRP20151328 T1 HR P20151328T1 HR P20151328T T HRP20151328T T HR P20151328TT HR P20151328 T HRP20151328 T HR P20151328T HR P20151328 T1 HRP20151328 T1 HR P20151328T1
Authority
HR
Croatia
Prior art keywords
solvent
image
amino acid
dimethyltetrahydro
cyclopenta
Prior art date
Application number
HRP20151328TT
Other languages
English (en)
Inventor
Tibor Musil
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HRP20151328T1 publication Critical patent/HRP20151328T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (10)

1. Postupak za pripravu benzil [(3aS,4R,6S,6aR)-6-hidroksi-2,2-dimetiltetrahidro-3aH-ciklopenta[d][1,3]dioksol-4-il]karbamata (VI), [image] naznačen time da sadrži korake (a) miješanje spoja s formulom (III), [image] s 0.5 do 0.8 ekvivalenata enantiomerno čiste zaštićene amino kiseline odabrane od L-Boc-fenilalanina ili L-Boc-leucina da se dobije diastereoizomerna sol; (b) kristalizaciju navedene soli da nastane zaštićena sol amino kiseline spoja s formulom (IV), [image] (c) obradu zaštićene soli amino kiseline spoja s formulom (IV) s kiselinom; i (d) reakciju produkta iz koraka c) s benzil kloroformatom u prisutnosti prikladne baze, kao što je kalijev karbonat.
2. Postupak prema zahtjevu 1, naznačen time da je otapalo iz koraka (a) odabrano od alifatskih alkohola, alifatskih estera, alifatskih ketona, aromatskih otapala i njihovih smjesa.
3. Postupak prema zahtjevu 2, naznačen time da je otapalo iz koraka (a) smjesa izo-propanola i toluena.
4. Postupak prema zahtjevu 2, naznačen time da je otapalo iz koraka (a) izo-propanol.
5. Postupak prema zahtjevu 2, naznačen time da je otapalo iz koraka (a) smjesa metil izo-butil ketona i toluena.
6. Postupak prema zahtjevu 2, naznačen time da je otapalo iz koraka (a) metil izo-butil keton.
7. Postupak prema bilo kojem od zahtjeva 1-6 naznačen time da je enantiomerno čista zaštićena amino kiselina L-Boc-fenilalanin.
8. Postupak prema bilo kojem od zahtjeva 1-6 naznačen time da je enantiomerno čista zaštićena amino kiselina L-Boc-leucin.
9. Intermedijerni spoj naznačen time da je (3aS,4R,6S,6aR)-6-hidroksi-2,2-dimetiltetrahidro-3aH-ciklopenta[d][1,3]dioksol-4-aminij (2S)-2-[(tert-butoksikarbonil)amino]-3-fenilpropanoat (Va), [image]
10. Intermedijerni spoj naznačen time da je (3aS,4R,6S,6aR)-6-hidroksi-2,2-dimetiltetrahidro-3aH-ciklopenta[d][1,3]dioksol-4-aminij (2S)-2-[(tert-butoksikarbonil)amino]-4-metilpentanoat (Vb), [image]
HRP20151328TT 2011-05-13 2012-05-11 POSTUPAK ZA PRIPRAVU BENZIL[(3aS,4R,6S,6aR)-6-HIDROKSI-2,2- DIMETILTETRAHIDRO-3aH-CIKLOPENTA[d][1,3]DIOKSOL]-4-IL]KARBAMATA I INTERMEDIJERI U POSTUPKU HRP20151328T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161485691P 2011-05-13 2011-05-13
US201161540084P 2011-09-28 2011-09-28
EP12785416.4A EP2707363B1 (en) 2011-05-13 2012-05-11 A process for the preparation of benzyl [(3as,4r,6s,6ar)-6-hydroxy-2,2- dimethyltetrahydro-3ah-cyclopenta[d][1,3]dioxol]-4-yl]carbamate and intermediates in the process
PCT/SE2012/050498 WO2012158099A1 (en) 2011-05-13 2012-05-11 A process for the preparation of benzyl [(3as,4r,6s,6ar)-6-hydroxy-2,2- dimethyltetrahydro-3ah-cyclopenta[d][1,3]dioxol]-4-yl]carbamate and intermediates in the process

Publications (1)

Publication Number Publication Date
HRP20151328T1 true HRP20151328T1 (hr) 2016-01-01

Family

ID=47177189

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20151328TT HRP20151328T1 (hr) 2011-05-13 2012-05-11 POSTUPAK ZA PRIPRAVU BENZIL[(3aS,4R,6S,6aR)-6-HIDROKSI-2,2- DIMETILTETRAHIDRO-3aH-CIKLOPENTA[d][1,3]DIOKSOL]-4-IL]KARBAMATA I INTERMEDIJERI U POSTUPKU

Country Status (26)

Country Link
US (1) US9079873B2 (hr)
EP (1) EP2707363B1 (hr)
JP (1) JP6023795B2 (hr)
KR (1) KR20140028070A (hr)
CN (1) CN103534245B (hr)
AR (1) AR086351A1 (hr)
AU (1) AU2012256439B2 (hr)
BR (1) BR112013028936B1 (hr)
CA (1) CA2834935A1 (hr)
CY (1) CY1117592T1 (hr)
DK (1) DK2707363T3 (hr)
ES (1) ES2556833T3 (hr)
HR (1) HRP20151328T1 (hr)
HU (1) HUE027145T2 (hr)
IL (1) IL229075A (hr)
MX (1) MX2013013221A (hr)
MY (1) MY163203A (hr)
PL (1) PL2707363T3 (hr)
PT (1) PT2707363E (hr)
RS (1) RS54443B1 (hr)
RU (1) RU2588673C2 (hr)
SG (1) SG194585A1 (hr)
SI (1) SI2707363T1 (hr)
SM (1) SMT201500309B (hr)
TW (1) TWI537256B (hr)
WO (1) WO2012158099A1 (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104513221A (zh) * 2013-09-26 2015-04-15 上海科胜药物研发有限公司 一种制备光学活性的替卡格雷中间体的方法
CN108484566A (zh) * 2018-02-26 2018-09-04 苏州楚凯药业有限公司 一种替格瑞洛关键中间体的制备方法
CN117551071A (zh) * 2023-10-13 2024-02-13 重庆普佑生物医药有限公司 替卡格雷中间体及其制备方法和应用该中间体的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702772D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
US6316671B1 (en) * 1997-11-28 2001-11-13 Universite De Rouen Method for splitting 1-amino-alkan-2-ol compounds
TWI229674B (en) * 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
JP4406483B2 (ja) * 1999-11-17 2010-01-27 株式会社デ・ウエスタン・セラピテクス研究所 光学活性2−アミノシクロヘキサノール誘導体の製造方法
GB0013488D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
JP2005104874A (ja) * 2003-09-29 2005-04-21 Yamakawa Yakuhin Kogyo Kk 光学活性なα−アミノ−ε−カプロラクタムまたはその塩の製造方法および製造の中間体
JPWO2007055180A1 (ja) * 2005-11-09 2009-04-30 東レ・ファインケミカル株式会社 光学活性トランス−2−アミノシクロヘキサノールおよびその誘導体の製造方法
JP2009023978A (ja) * 2007-07-23 2009-02-05 Kaneka Corp トランス−2−ベンジロキシシクロヘキシルアミンの製造法
TWI496776B (zh) * 2007-11-15 2015-08-21 Astrazeneca Ab 製備(3aR,4S,6R,6aS)-6-胺基-2,2-二甲基四氫-3aH-環戊并[d][1,3]二氧雜環戊烯-4-醇之純非對映異構性之二苯甲醯-L-酒石酸鹽之方法
RU2400478C1 (ru) * 2009-02-24 2010-09-27 Учреждение Российской академии наук Институт органической химии Уфимского научного центра РАН Способ получения (4s,5s)-4,5-о-изопропилиденциклопент-2-ен-1-она
JP2013500347A (ja) * 2009-07-27 2013-01-07 オースペックス ファーマシューティカルズ,インク. P2y12受容体のシクロプロピルモジュレーター

Also Published As

Publication number Publication date
PL2707363T3 (pl) 2016-02-29
SI2707363T1 (sl) 2016-01-29
ES2556833T3 (es) 2016-01-20
US20140135509A1 (en) 2014-05-15
CN103534245B (zh) 2015-08-19
IL229075A (en) 2016-10-31
RU2588673C2 (ru) 2016-07-10
TWI537256B (zh) 2016-06-11
MY163203A (en) 2017-08-15
AR086351A1 (es) 2013-12-04
SG194585A1 (en) 2013-12-30
KR20140028070A (ko) 2014-03-07
AU2012256439B2 (en) 2015-10-22
IL229075A0 (en) 2013-12-31
HK1195307A1 (zh) 2014-11-07
CN103534245A (zh) 2014-01-22
SMT201500309B (it) 2016-01-08
RU2013150325A (ru) 2015-06-20
CY1117592T1 (el) 2017-04-26
DK2707363T3 (en) 2015-12-21
RS54443B1 (en) 2016-06-30
BR112013028936A2 (pt) 2016-08-09
WO2012158099A1 (en) 2012-11-22
EP2707363A4 (en) 2014-11-12
CA2834935A1 (en) 2012-11-22
BR112013028936B1 (pt) 2021-10-19
JP2014524885A (ja) 2014-09-25
MX2013013221A (es) 2013-12-02
EP2707363B1 (en) 2015-10-21
JP6023795B2 (ja) 2016-11-09
TW201249820A (en) 2012-12-16
PT2707363E (pt) 2016-01-07
EP2707363A1 (en) 2014-03-19
AU2012256439A1 (en) 2013-05-02
HUE027145T2 (en) 2016-08-29
US9079873B2 (en) 2015-07-14

Similar Documents

Publication Publication Date Title
MX2009009182A (es) Co-cristales y composiciones farmaceuticas que los comprenden.
IN2014MN02644A (hr)
PH12013501197B1 (en) Indeno-fused ring compounds
RS52437B (en) ACTIVE INHIBITORS Enzyme E1
GEP20156328B (en) Solid pharmaceutical compositions and processes for their production
RS54785B1 (sr) Pirolopirazin-spirociklični piperidin amidi kao modulatori jonskih kanala
PE20081251A1 (es) Formas cristalinas del acido (3s)-3-[n-(n'-(2-terc-butilfenil)oxamil)alaninil]amino-5-(2',3',5',6'-tetrafluorofenoxi)-4-oxopentanoico
NZ708350A (en) Anthelmintic compounds and compositions and method of using thereof
IN2014DN03424A (hr)
HRP20151328T1 (hr) POSTUPAK ZA PRIPRAVU BENZIL[(3aS,4R,6S,6aR)-6-HIDROKSI-2,2- DIMETILTETRAHIDRO-3aH-CIKLOPENTA[d][1,3]DIOKSOL]-4-IL]KARBAMATA I INTERMEDIJERI U POSTUPKU
HRP20170167T1 (hr) Sinteza spojeva triazolopirimidina
HRP20080510T3 (hr) Postupak za priređivanje optički aktivnih derivata 2-(2-piridilmetilsulfinil)-benzimidazola putem inkluzijskog kompleksa s 1,1'-binaftalen-2,2' diolom
EP2854819A4 (en) NEW SALICYLIC ACID DERIVATIVES, PHARMACEUTICALLY UNSUITABLE SALT THEREOF, COMPOSITION, AND METHOD FOR THE USE THEREOF
UA113615C2 (xx) Спосіб отримання 2-аміно-n-(2,2,2-трифторетил)ацетаміду
HRP20161145T1 (hr) Postupak za pripravu l-argininske soli perindoprila
HRP20211031T1 (hr) Postupak za proizvodnju novog spoja koji sadrži dušik ili njegove soli i proizvodnja njihovog međuprodukta
PE20131394A1 (es) Monohidrato de derivados de aza-adamantano
MY166378A (en) Zeoltic materials and methods for their preparation using alkenyltrialkylammonium compounds
UA111580C2 (uk) Кристалізація гідрохлориду 4'-епідаунорубіцину
HRP20161031T1 (hr) POSTUPCI ZA PRIPREMANJE (3R,3aS,6aR) HEKSAHIDRO-FURO[2,3-b]FURAN-3-OLA
HRP20200488T1 (hr) Proizvodnja 4,5,6,7-tetrahidroizozaksolo[5,4-c]piridin-3-ola
EP2690087A4 (en) NEW CRYSTAL FORMULA VII OF AGOMELATIN, MANUFACTURING METHOD AND USE THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
WO2011102640A3 (en) Method for preparing sitagliptin and amine salt intermediates used therein
IL220708A (en) Compounds whose molecule contains groups 2 - (phenyl / heteroaryl) - [3,1] oxazolo [4,5– d] pyrimidine and carboxy - (heterocyclic nitrogen) carbonyl, also a process for their preparation and pharmaceutical preparations containing them
RS54669B1 (en) PROCEDURE FOR INSULATION OF ENANTIOMERIC COMPONENTS FROM ENANTIOMERIC MIXTURES BY CRYSTALIZATION BY CONTROLLED CELL SIZE